Document Detail

Effect of nebulized furosemide in terminally ill cancer patients with dyspnea.
MedLine Citation:
PMID:  14575057     Owner:  NLM     Status:  MEDLINE    
We evaluated the effect of ultrasonically nebulized furosemide (20 mg) on dyspnea uncontrollable by standard therapy in patients with terminal cancer. Dyspnea was evaluated using the Cancer Dyspnea Scale (CDS) before and 60 min after inhalation. Changes in arterial blood gases, hemoglobin oxygen saturation (SpO2), heart rate (HR), and respiratory rate (RR) also were evaluated. In 12 of 15 patients (80%), total dyspnea scores by CDS improved significantly after inhalation of furosemide (P = 0.007), especially concerning a reduced sense of effort (P = 0.013) and reduced anxiety (P = 0.04). No significant changes were observed in the partial pressure of oxygen in arterial blood (PaO2), the partial pressure of carbon dioxide in arterial blood (PaCO2), SpO2, HR, or RR. Inhalation of nebulized furosemide appears to be effective against dyspnea in terminally ill cancer patients.
Hiroyuki Kohara; Hiroshi Ueoka; Keisuke Aoe; Tadashi Maeda; Hiroyasu Takeyama; Ryusei Saito; Yasuo Shima; Yosuke Uchitomi
Related Documents :
9288687 - Oxygen transport and utilization during feeding in the young lamb.
16098947 - Oxygen tensioactivity on liquid-metal drops.
10833357 - The effect of inspired oxygen concentration on the ventilation-perfusion distribution i...
9539067 - Oxygen supply dependency can characterize septic shock.
2951517 - Smooth muscle relaxing, acute and long-term blood pressure lowering effects of atriopep...
3940797 - Balloon topography. a simple method of evaluating anal function.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of pain and symptom management     Volume:  26     ISSN:  0885-3924     ISO Abbreviation:  J Pain Symptom Manage     Publication Date:  2003 Oct 
Date Detail:
Created Date:  2003-10-23     Completed Date:  2003-12-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8605836     Medline TA:  J Pain Symptom Manage     Country:  United States    
Other Details:
Languages:  eng     Pagination:  962-7     Citation Subset:  IM    
Department of Internal Medicine, National Sanyo Hospital, Yamaguchi, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chloride Channels / antagonists & inhibitors
Critical Illness / therapy*
Dyspnea / drug therapy*,  etiology*
Furosemide / administration & dosage*
Nebulizers and Vaporizers
Neoplasms / complications*
Reg. No./Substance:
0/Chloride Channels; 54-31-9/Furosemide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ventilator withdrawal: procedures and outcomes. Report of a collaboration between a critical care di...
Next Document:  Report on avian influenza in the Eastern Hemisphere during 1997-2002.